231 related articles for article (PubMed ID: 22162577)
1. Prognostic effect of circulating adiponectin in a randomized 2 x 2 trial of low-dose tamoxifen and fenretinide in premenopausal women at risk for breast cancer.
Macis D; Gandini S; Guerrieri-Gonzaga A; Johansson H; Magni P; Ruscica M; Lazzeroni M; Serrano D; Cazzaniga M; Mora S; Feroce I; Pizzamiglio M; Sandri MT; Gulisano M; Bonanni B; Decensi A
J Clin Oncol; 2012 Jan; 30(2):151-7. PubMed ID: 22162577
[TBL] [Abstract][Full Text] [Related]
2. Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.
Decensi A; Robertson C; Guerrieri-Gonzaga A; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Galimberti V; Cassano E; Moroni SM; Formelli F; Lien EA; Pelosi G; Johnson KA; Bonanni B
J Clin Oncol; 2009 Aug; 27(23):3749-56. PubMed ID: 19597031
[TBL] [Abstract][Full Text] [Related]
3. Effect of fenretinide and low-dose tamoxifen on insulin sensitivity in premenopausal women at high risk for breast cancer.
Johansson H; Gandini S; Guerrieri-Gonzaga A; Iodice S; Ruscica M; Bonanni B; Gulisano M; Magni P; Formelli F; Decensi A
Cancer Res; 2008 Nov; 68(22):9512-8. PubMed ID: 19010927
[TBL] [Abstract][Full Text] [Related]
4. Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide.
Johansson H; Bonanni B; Gandini S; Guerrieri-Gonzaga A; Cazzaniga M; Serrano D; Macis D; Puccio A; Sandri MT; Gulisano M; Formelli F; Decensi A
Breast Cancer Res Treat; 2013 Dec; 142(3):569-78. PubMed ID: 24241787
[TBL] [Abstract][Full Text] [Related]
5. Preliminary results on safety and activity of a randomized, double-blind, 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in premenopausal women.
Guerrieri-Gonzaga A; Robertson C; Bonanni B; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Formelli F; Intra M; Latronico A; Franchi D; Pelosi G; Johnson K; Decensi A
J Clin Oncol; 2006 Jan; 24(1):129-35. PubMed ID: 16382122
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin: a risk biomarker and attractive target for chemoprevention.
Fabian CJ
J Clin Oncol; 2012 Jan; 30(2):124-6. PubMed ID: 22162567
[No Abstract] [Full Text] [Related]
7. Relationships between plasma insulin-like growth factor-I and insulin-like growth factor binding protein-3 and second breast cancer risk in a prevention trial of fenretinide.
Decensi A; Veronesi U; Miceli R; Johansson H; Mariani L; Camerini T; Di Mauro MG; Cavadini E; De Palo G; Costa A; Perloff M; Malone WF; Formelli F
Clin Cancer Res; 2003 Oct; 9(13):4722-9. PubMed ID: 14581342
[TBL] [Abstract][Full Text] [Related]
8. The relation of leptin and adiponectin with breast density among premenopausal women.
Maskarinec G; Woolcott C; Steude JS; Franke AA; Cooney RV
Eur J Cancer Prev; 2010 Jan; 19(1):55-60. PubMed ID: 19927000
[TBL] [Abstract][Full Text] [Related]
9. Fenretinide in Young Women at Genetic or Familial Risk of Breast Cancer: A Placebo-Controlled Biomarker Trial.
Aristarco V; Serrano D; Maisonneuve P; Guerrieri-Gonzaga A; Lazzeroni M; Feroce I; Macis D; Cavadini E; Albertazzi E; Jemos C; Omodeo Salè E; Cortesi L; Massarut S; Gulisano M; Daidone MG; Johansson H; Bonanni B
Cancer Prev Res (Phila); 2024 Jun; 17(6):255-263. PubMed ID: 38530139
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women.
Serrano D; Gandini S; Guerrieri-Gonzaga A; Feroce I; Johansson H; Macis D; Aristarco V; Bonanni B; DeCensi A
Cancer Prev Res (Phila); 2018 Dec; 11(12):811-818. PubMed ID: 30352838
[TBL] [Abstract][Full Text] [Related]
11. Circulating leptin and adiponectin, and breast density in premenopausal Mexican women: the Mexican Teachers' Cohort.
Dossus L; Rinaldi S; Biessy C; Hernandez M; Lajous M; Monge A; Ortiz-Panozo E; Yunes E; Lopez-Ridaura R; Torres-Mejía G; Romieu I
Cancer Causes Control; 2017 Sep; 28(9):939-946. PubMed ID: 28677026
[TBL] [Abstract][Full Text] [Related]
12. Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women.
Jürimäe J; Jürimäe T; Ring-Dimitriou S; LeMura LM; Arciero PJ; von Duvillard SP
Metabolism; 2009 May; 58(5):638-43. PubMed ID: 19375586
[TBL] [Abstract][Full Text] [Related]
13. Fifteen-year results of a randomized phase III trial of fenretinide to prevent second breast cancer.
Veronesi U; Mariani L; Decensi A; Formelli F; Camerini T; Miceli R; Di Mauro MG; Costa A; Marubini E; Sporn MB; De Palo G
Ann Oncol; 2006 Jul; 17(7):1065-71. PubMed ID: 16675486
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of breast cancer: the Italian experience.
Decensi A; Bonanni B; Guerrieri-Gonzaga A; Torrisi R; Manetti L; Robertson C; De Palo G; Formelli F; Costa A; Veronesi U
J Cell Biochem Suppl; 2000; 34():84-96. PubMed ID: 10762020
[TBL] [Abstract][Full Text] [Related]
15. Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.
Zujewski J
Environ Mol Mutagen; 2002; 39(2-3):264-70. PubMed ID: 11921197
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
[TBL] [Abstract][Full Text] [Related]
17. 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1.
Amir E; Cecchini RS; Ganz PA; Costantino JP; Beddows S; Hood N; Goodwin PJ
Breast Cancer Res Treat; 2012 Jun; 133(3):1077-88. PubMed ID: 22415479
[TBL] [Abstract][Full Text] [Related]
18. [Breakthrough in breast cancer chemoprevention].
Kahán Z; Thurzó L
Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
[TBL] [Abstract][Full Text] [Related]
19. Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.
Veronesi U; De Palo G; Marubini E; Costa A; Formelli F; Mariani L; Decensi A; Camerini T; Del Turco MR; Di Mauro MG; Muraca MG; Del Vecchio M; Pinto C; D'Aiuto G; Boni C; Campa T; Magni A; Miceli R; Perloff M; Malone WF; Sporn MB
J Natl Cancer Inst; 1999 Nov; 91(21):1847-56. PubMed ID: 10547391
[TBL] [Abstract][Full Text] [Related]
20. Fenretinide in the prevention of breast cancer in premenopausal women: fluke or fact?
Pritchard KI
Ann Oncol; 2006 Jul; 17(7):1035-6. PubMed ID: 16766581
[No Abstract] [Full Text] [Related]
[Next] [New Search]
